Navigation Links
Waging War on Wrinkles: Infini Cosmetic Associates Now Offers Recent FDA Approved Dysport - The Botox Alternative
Date:7/19/2009

Infini Cosmetic Associates in Scottsdale will carry Dysport™ the newly FDA approved wrinkle remover and rival to Botox®. Founder and Chief Surgeon, Dr. William Hall has performed thousands of injections over the last six years and trained many other professionals on Botox® and other injectable dermal fillers. Dr. Hall is very skilled in many of the advanced uses of Botox for: hyperhidrosis (excessive sweating) and nervous tics in the face, neck bands and wrinkles, chin creases and dimpling, lip lines, and lower facial shaping.

Scottsdale, AZ (PRWEB) July 19, 2009 -- Dr. William Hall, Founder and Chief Surgeon at Infini Cosmetic Associates in Scottsdale, announced that Infini Cosmetic Associates will carry Dysport™ the newly FDA approved wrinkle remover and rival to Botox®. Dr. Hall has performed thousands of injections over the last six years and trained many other professionals on Botox® and other injectable dermal fillers. Dr. Hall is very skilled in many of the advanced uses of Botox for: hyperhidrosis (excessive sweating) and nervous tics in the face, neck bands and wrinkles, chin creases and dimpling, lip lines, and lower facial shaping.

The arrival of Dysport™ into the U.S. aesthetics marketplace will no doubt increase competition between the two wrinkle treatments and multiply physician choices and cosmetic options within the same medical practice.

"This is a burgeoning industry and dermal fillers are very popular, so as doctors we are always being introduced to new products that compete with ones we already use - for example I use both Restylane® and Juvederm®," Hall stated. "I have used and trained with Botox® for years and patients love the results, I will offer Dysport™ too, but ultimately, the patients decide after they try both products and see the lasting results," Dr. Hall concluded.

Medicis, a dermal filler leader (known for their popular Restylane® and Perlane® facial fillers) will promote the Dysport™ brand as part of a U.S. sales agreement with the manufacturer, Ipsen. The addition of Dysport™ to their dermal filler arsenal positions Medic as a threatening opponent to the Allergan empire and their line of beauty treatments (Botox® and the Juvederm® - hyaluronic acid gel fillers).

BOTOX® Cosmetic is the solution for many wrinkles, which are actually creases that have been worn into the skin by making the same expression thousands of times. Hall explains - "expression lines" are often called frown lines, crow's feet, or forehead lines and appear due to the contraction of a muscle under the skin in that area. BOTOX® Cosmetic offers a much safer, less invasive option than cutting the muscle and provides more predictable and enhanced results. Some have called this unique therapy "a facelift in a bottle." Now, with Dysport™ there are more products to wage war on age.

Botox and dermal fillers produce long-lasting, amazing results. Visit http://www.infiniskin.com/Wrinkles.html to find out more about wrinkle restoration. For more information about Infini Cosmetic Associates, visit www.infiniskin.com to see photo galleries and the amazing special offers on Botox and dermal fillers. To set up a free consultation, call 480-946-7100.

###

Read the full story at http://www.prweb.com/releases/2009/07/prweb2655704.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. StructuRad Launches MacroLive(TM) with INFINITT and RamSoft at RSNA 2007
2. AutoGenomics Receives FDA Clearance for its INFINITI(TM) Warfarin Assay
3. Management Consultancy Announces Inaugural Infinitive Championship Series
4. AutoGenomics INFINITI Analyzer Receives Artistic Design Award
5. Infinity Business Systems of Tampa Expands Into Sarasota / Bradenton
6. Thank You, Dunder Mifflin Infinity
7. Infinity Property and Casualty Corporation Declares Quarterly Dividend
8. Purdue Pharma L.P. Announces a Global Strategic Alliance With Infinity Pharmaceuticals to Advance Discovery and Development Programs in Oncology and Neuropathic Pain
9. ProStor InfiniVault-DICOM Storage System Debuts in Rorke Data Booth at RSNA
10. Shaklee Hits the Road With Its Infinite Possibilities Tour
11. Shaklee Hits the Road with its Infinite Possibilities Tour in New York, NY
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... Pennsylvania (PRWEB) , ... March 24, 2017 , ... ... recycling solutions for contaminated soil, dredged material, and hazardous and non-hazardous materials announced ... in Allentown, Pennsylvania. This acquisition will add four additional processing facilities and ...
(Date:3/24/2017)... NY (PRWEB) , ... March 24, 2017 , ... ... “Fighting Infection,” which will spark a conversation on the current obstacles facing infection ... number of completely preventable deaths caused by these infections. , The print ...
(Date:3/24/2017)... ... March 24, 2017 , ... Digital Scientists, a software innovation ... the opening of a Greenville, South Carolina location. The lab has set ... Greenville. , “We’ve been working with South Carolina clients for years from our office ...
(Date:3/24/2017)... ... March 24, 2017 , ... According to a new study ... because it does not obey the rules Congress has directed the CBO to follow. ... the GOP reform would restore. Yet, it estimates a reduction in employer-based coverage due ...
(Date:3/24/2017)... ... March 24, 2017 , ... The iaedp Foundation, the premier provider of educational ... those suffering from the full spectrum of disordered eating, announced today that the 2017 ... nearly all 50 states and several countries converged on the Green Valley Resort in ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... Research and Markets has announced the addition of the "Global Idiopathic ... ... strong with a total of 97 drug candidates. Pharma giant such as ... in the development of the IPF therapeutics. The IPF pipeline comprised of ... are in Phase II stage, 12 are in Phase I stage, 39 ...
(Date:3/24/2017)... , March 24, 2017 A ReportsnReports.com ... has been growing rapidly as the global sales of Adcetris and ... growth in the antibody drug conjugates market is driven by large ... cancer and wider therapeutic window offered by ADCs. ... Browse 3 Tables and 94 Figures, ...
(Date:3/24/2017)... Today Stock-Callers.com have issued research reports ... Inc. (NASDAQ: NVCN), Hologic Inc. (NASDAQ: HOLX), Edwards Lifesciences Corp. ... ). These companies are part of the Healthcare sector, which ... 23 rd , 2017, with the NYSE Health Care Index ... companies in the S&P 500 were down about 0.4% as ...
Breaking Medicine Technology: